Edition:
United Kingdom

Qiagen NV (QGEN.N)

QGEN.N on New York Stock Exchange

39.04USD
22 Feb 2019
Change (% chg)

$0.26 (+0.67%)
Prev Close
$38.78
Open
$38.68
Day's High
$39.08
Day's Low
$38.67
Volume
249,374
Avg. Vol
311,932
52-wk High
$39.45
52-wk Low
$31.10

Chart for

About

QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and... (more)

Overall

Beta: 1.13
Market Cap(Mil.): $7,880.51
Shares Outstanding(Mil.): 230.83
Dividend: 1.08
Yield (%): --

Financials

  QGEN.N Industry Sector
P/E (TTM): 104.06 69.44 33.70
EPS (TTM): 0.33 -- --
ROI: 1.87 8.92 14.45
ROE: 2.97 10.08 15.96

BRIEF-Qiagen Announces New Collaboration With Novartis

* QIAGEN ANNOUNCES NEW COLLABORATION TO DEVELOP COMPANION DIAGNOSTIC TO GUIDE TREATMENT FOR PATIENTS WITH PIK3CA-MUTATED ADVANCED BREAST CANCER

06 Dec 2018

BRIEF-Blocktrade - Qiagen Bookrunner Says Deal Upsized To $500 Mln On Convertible Notes

* BLOCKTRADE - QIAGEN: BOOKRUNNER SAYS DEAL UPSIZED TO $500M; BOOKS TO CLOSE AT 13.30 UK Source text for Eikon: Further company coverage:

06 Nov 2018

Earnings vs. Estimates